BACTERIAL VAGINOSIS
Clinical trials for BACTERIAL VAGINOSIS explained in plain language.
Never miss a new study
Get alerted when new BACTERIAL VAGINOSIS trials appear
Sign up with your email to follow new studies for BACTERIAL VAGINOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaginal treatment aims to restore healthy bacteria balance
Disease control Not yet recruitingThis early-stage study is testing whether a vaginal treatment containing specific healthy bacteria can successfully take hold and help control bacterial vaginosis. It will involve 71 women who previously tried the treatment in another study but still have an imbalance in their va…
Matched conditions: BACTERIAL VAGINOSIS
Phase: EARLY_PHASE1 • Sponsor: Caroline Mitchell • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Milk protein could offer women a new way to fight infections without antibiotics
Disease control Not yet recruitingThis study is checking if it's possible to run a larger future trial. That trial would test whether a natural protein from cow's milk, called lactoferrin, can be used as a vaginal treatment for common infections like bacterial vaginosis (BV) and thrush. Researchers will recruit 1…
Matched conditions: BACTERIAL VAGINOSIS
Phase: NA • Sponsor: Guy's and St Thomas' NHS Foundation Trust • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New combo pill aims to stop pesky vaginal infection from coming back
Prevention Not yet recruitingThis study aims to see if adding a new oral capsule called BPR-101 to a standard antibiotic (metronidazole) can help prevent bacterial vaginosis (BV) from recurring. It will involve about 80 women aged 18-50 who have been diagnosed with BV. The trial will compare the new combinat…
Matched conditions: BACTERIAL VAGINOSIS
Phase: PHASE2 • Sponsor: Chengdu Syncor Pharmaceutical Co., Ltd. • Aim: Prevention
Last updated Mar 25, 2026 14:07 UTC
-
First human tests begin for new vaginal infection treatment
Knowledge-focused Not yet recruitingThis early-stage study aims to test the safety and measure how the body processes a new vaginal treatment called GenSci142 for bacterial vaginosis. The trial will enroll 30 healthy Chinese women who will receive either the experimental treatment or a placebo. Researchers will mon…
Matched conditions: BACTERIAL VAGINOSIS
Phase: PHASE1 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Mar 18, 2026 14:40 UTC